Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 (2018)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1161/JAHA.118.009260
- Subjects: INFARTO DO MIOCÁRDIO; AGREGAÇÃO PLAQUETÁRIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the american heart association
- ISSN: 2047-9980
- Volume/Número/Paginação/Ano: v. 7, n. 22, article ID e009260, 13p, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
BONACA, Marc P. et al. Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54. Journal of the american heart association, v. 7, n. 22, 2018Tradução . . Disponível em: https://doi.org/10.1161/JAHA.118.009260. Acesso em: 10 jan. 2026. -
APA
Bonaca, M. P., Wiviott, S. D., Morrow, D. A., Steg, P. G., Hamm, C., Bhatt, D. L., et al. (2018). Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54. Journal of the american heart association, 7( 22). doi:10.1161/JAHA.118.009260 -
NLM
Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Nicolau JC. Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 [Internet]. Journal of the american heart association. 2018 ; 7( 22):[citado 2026 jan. 10 ] Available from: https://doi.org/10.1161/JAHA.118.009260 -
Vancouver
Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Nicolau JC. Reduction in aubtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 [Internet]. Journal of the american heart association. 2018 ; 7( 22):[citado 2026 jan. 10 ] Available from: https://doi.org/10.1161/JAHA.118.009260 - Oclusão de comunicação interventricular pós-infarto com prótese percutânea CERA
- Spontaneous MI After Non–ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- Timing, Profile, and Predictors of Spontaneous Myocardial Infarction Following a Non-ST-Segment Elevation Acute Coronary Syndrome Event: Insights From the TRILOGY-ACS Trial
- The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial
- Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
- Left ventricular hypertrophy and QTc dispersion are predictors of long-term mortality in subjects with type 2 diabetes
- P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
Informações sobre o DOI: 10.1161/JAHA.118.009260 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
